Trader consensus on Polymarket heavily favors "No" at 94% implied probability for Anthropic being acquired before 2027, driven by its explosive growth as an independent AI lab. A massive $30 billion Series G funding round in February 2026 valued the Claude developer at $380 billion post-money, enabling acquisitions like the $400 million Coefficient Bio deal in early April for biotech AI expansion, alongside Bun and Vercept integrations to bolster coding and agent capabilities. IPO preparations, including a recent tender offer, underscore a path to public markets rather than sale, amid $30 billion annual run-rate revenue and strategic pacts with Broadcom and pharma giants. While regulatory scrutiny or an AI market downturn could theoretically prompt a pivot, Anthropic's financial fortress and competitive edge versus OpenAI make a buyout improbable.
Polymarket verilerine atıfta bulunan deneysel AI tarafından oluşturulmuş özet. Bu bir işlem tavsiyesi değildir ve bu piyasanın nasıl çözümlendiğinde hiçbir rolü yoktur. · Güncellendi$14,101 Hac.
$14,101 Hac.
31 Ara 2026
$14,101 Hac.
$14,101 Hac.
31 Ara 2026
This market will resolve to “Yes” if credible reporting confirms that any entity enters into an agreement to acquire Anthropic by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.Trader consensus on Polymarket heavily favors "No" at 94% implied probability for Anthropic being acquired before 2027, driven by its explosive growth as an independent AI lab. A massive $30 billion Series G funding round in February 2026 valued the Claude developer at $380 billion post-money, enabling acquisitions like the $400 million Coefficient Bio deal in early April for biotech AI expansion, alongside Bun and Vercept integrations to bolster coding and agent capabilities. IPO preparations, including a recent tender offer, underscore a path to public markets rather than sale, amid $30 billion annual run-rate revenue and strategic pacts with Broadcom and pharma giants. While regulatory scrutiny or an AI market downturn could theoretically prompt a pivot, Anthropic's financial fortress and competitive edge versus OpenAI make a buyout improbable.
This market will resolve to “Yes” if credible reporting confirms that any entity enters into an agreement to acquire Anthropic by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.
Piyasa Açıldı: Nov 12, 2025, 5:14 PM ET
Hacim
$14,101Bitiş Tarihi
31 Ara 2026Piyasa Açıldı
Nov 12, 2025, 5:14 PM ETResolver
0x65070BE91...This market will resolve to “Yes” if credible reporting confirms that any entity enters into an agreement to acquire Anthropic by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.Trader consensus on Polymarket heavily favors "No" at 94% implied probability for Anthropic being acquired before 2027, driven by its explosive growth as an independent AI lab. A massive $30 billion Series G funding round in February 2026 valued the Claude developer at $380 billion post-money, enabling acquisitions like the $400 million Coefficient Bio deal in early April for biotech AI expansion, alongside Bun and Vercept integrations to bolster coding and agent capabilities. IPO preparations, including a recent tender offer, underscore a path to public markets rather than sale, amid $30 billion annual run-rate revenue and strategic pacts with Broadcom and pharma giants. While regulatory scrutiny or an AI market downturn could theoretically prompt a pivot, Anthropic's financial fortress and competitive edge versus OpenAI make a buyout improbable.
This market will resolve to “Yes” if credible reporting confirms that any entity enters into an agreement to acquire Anthropic by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.
Hacim
$14,101Bitiş Tarihi
31 Ara 2026Piyasa Açıldı
Nov 12, 2025, 5:14 PM ETResolver
0x65070BE91...Trader consensus on Polymarket heavily favors "No" at 94% implied probability for Anthropic being acquired before 2027, driven by its explosive growth as an independent AI lab. A massive $30 billion Series G funding round in February 2026 valued the Claude developer at $380 billion post-money, enabling acquisitions like the $400 million Coefficient Bio deal in early April for biotech AI expansion, alongside Bun and Vercept integrations to bolster coding and agent capabilities. IPO preparations, including a recent tender offer, underscore a path to public markets rather than sale, amid $30 billion annual run-rate revenue and strategic pacts with Broadcom and pharma giants. While regulatory scrutiny or an AI market downturn could theoretically prompt a pivot, Anthropic's financial fortress and competitive edge versus OpenAI make a buyout improbable.
Polymarket verilerine atıfta bulunan deneysel AI tarafından oluşturulmuş özet. Bu bir işlem tavsiyesi değildir ve bu piyasanın nasıl çözümlendiğinde hiçbir rolü yoktur. · Güncellendi
Harici bağlantılara dikkat edin.
Harici bağlantılara dikkat edin.
Sıkça Sorulan Sorular